BWA
CHRS icon

BDO Wealth Advisors’s Coherus Oncology CHRS Stock Holding History

BDO Wealth Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,200
Closed -$22K – 930
2020
Q3 		$22K Hold
1,200
– – ﹤0.01% 410
2020
Q2 		$21K Hold
1,200
– – ﹤0.01% 420
2020
Q1 		$19K Buy
+1,200
New +$22.2K ﹤0.01% 455

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BDO Wealth Advisors's CHRS Position: Q4 2020 in Review

BDO Wealth Advisors sold out of Coherus Oncology (CHRS) in Q4 2020, closing a stake of 1,200 shares — an estimated $22K sold.

BDO Wealth Advisors first reported a position in CHRS in Q1 2020 and held it in 3 quarters. The position peaked at $22K in Q3 2020. 196 funds tracked by Wall St. Rank hold CHRS as of Q4 2020.

  • BDO Wealth Advisors reported no remaining Coherus Oncology position as of Q4 2020 after selling out during the quarter.
  • BDO Wealth Advisors sold 1,200 Coherus Oncology shares in Q4 2020, an estimated $22K.
  • BDO Wealth Advisors first reported a position in Coherus Oncology in Q1 2020 and held it in 3 quarters.
  • BDO Wealth Advisors's Coherus Oncology position peaked at $22K in Q3 2020.
  • 196 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2020.

Based on BDO Wealth Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.